TI-Trust’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.58M Hold
2,230
– – 1.42% 20
2026
Q2
$2.67M Sell
2,230
-200
-8% -$204K 1.44% 18
2026
Q1
$2.24M Buy
2,430
+200
+9% +$203K 1.33% 20
2025
Q4
$2.4M Sell
2,230
-9
-0.4% -$8.61K 1.48% 17
2025
Q3
$1.71M Buy
2,239
+85
+4% +$63.3K 1.08% 23
2025
Q2
$1.68M Buy
2,154
+24
+1% +$18.6K 1.13% 22
2025
Q1
$1.76M Sell
2,130
-150
-7% -$125K 1.17% 20
2024
Q4
$1.76M Buy
2,280
+150
+7% +$124K 1.18% 21
2024
Q3
$1.89M Hold
2,130
– – 1.35% 19
2024
Q2
$1.93M Sell
2,130
-305
-13% -$244K 1.49% 18
2024
Q1
$1.89M Sell
2,435
-1,356
-36% -$965K 1.39% 18
2023
Q4
$2.21M Hold
3,791
– – 1.95% 12
2023
Q3
$2.04M Buy
3,791
+31
+0.8% +$16K 1.94% 14
2023
Q2
$1.76M Hold
3,760
– – 1.62% 17
2023
Q1
$1.29M Hold
3,760
– – 1.21% 23
2022
Q4
$1.38M Hold
3,760
– – 1.31% 23
2022
Q3
$1.22M Buy
3,760
+100
+3% +$31.7K 1.31% 23
2022
Q2
$1.19M Hold
3,660
– – 1.22% 23
2022
Q1
$1.05M Sell
3,660
-104
-3% -$26.8K 0.95% 29
2021
Q4
$1.04M Buy
+3,764
New +$954K 0.93% 30
2019
Q4
$481K Buy
+3,660
New +$424K 0.47% 65

Other funds holding LLY

TI-Trust's LLY Position: Q3 2026 in Review

TI-Trust held its Eli Lilly (LLY) position steady in Q3 2026 at 2,230 shares worth $2.58M. The position accounts for 1.42% of the portfolio, ranked #20.

TI-Trust first reported a position in LLY in Q4 2019 and has held it in 21 quarters since. The position peaked at $2.67M in Q2 2026. 1,879 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • TI-Trust held 2,230 shares of Eli Lilly worth $2.58M as of Q3 2026.
  • TI-Trust left its Eli Lilly share count unchanged in Q3 2026.
  • Eli Lilly made up 1.42% of TI-Trust's portfolio in Q3 2026, its #20 holding.
  • TI-Trust first reported a position in Eli Lilly in Q4 2019 and has held it in 21 quarters since.
  • TI-Trust's Eli Lilly position peaked at $2.67M in Q2 2026.
  • 1,879 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on TI-Trust's 13F filing for Q3 2026, filed 21 Oct 2026.